Cambcol Ltd (09351538): administration
- Status
- Administration ended
- Administration began
- 2024-05-03
- Administrators' firm
- Begbies Traynor
- Incorporated
- 2014-12-11
- Location
- Birmingham
- Industry
- 21100 Manufacture of basic pharmaceutical products
Why it went into administration
- COVID-19
- Cash flow / liquidity pressure
- Creditor pressure / legal action
From the administrators' statement
Cambcol is the designer, developer and seller of a high quality, medical collagen product for use in the treatment of wounds The products are produced in sponges which staunch bleeding and aid healing when applied directly to wounds.
Cambcol’s business developed from a successful business operated exporting chicken feet. Chicken feet were a by-product of the poultry industry, which would otherwise go into landfill, or be processed into pet food. The director, Jonathan Fitton, read that it was possible to extract collagen from the feet of chicken and wished to explore the commerciality of this further. After speaking to a biochemistry professor from Cambridge University, a plan was made to produce a medical product. Initially, this was going to be an application for chronic wounds, but this idea evolved into a revolutionary blood clotting collagen haemostatic sponge. The Company worked with top medics in the Ministry of Defence and National Health Service surgeons to deliver this medical device.
Cambcol retained the Intellectual Property of the product design and built a state of the art medical factory and offices in Littleport, Cambridgeshire, which was opened in 2020. In recent times, it is understood that the Company supplied thousands of products to assist with the Ukrainian war, with good results and feedback advising that the product had saved lives.
Administrators' statement of proposals (2024-07-02) · Companies House register